TXN's Manufacturing Expansion Continues: Can It Strengthen Margins?

Texas Instruments reported Q1 2026 gross margin of 58%, up 120 bps year over year, as revenue rose 19% to $4.83 billion and operating profit increased 37% to $1.81 billion. Operating margin expanded 490 bps to 37.5%, supported by higher factory utilization and demand in industrial and data center markets. The article also highlights declining capex guidance to $2-$3 billion from more than $4 billion over the past 12 months, which could further support margin expansion.

Analysis

TXN’s margin inflection is less about a cyclical rebound and more about a structural spread widening versus fab-light peers: once utilization gets above the threshold where fixed depreciation is absorbed, every incremental dollar of revenue should drop through at an unusually high rate. That makes the next 2-4 quarters the key window, because the market is likely still underestimating how quickly prior capex turns from an earnings drag into an operating leverage engine. The setup is especially powerful if industrial demand remains durable, since that mix supports both volume and pricing discipline.

The second-order winner is the analog supply chain itself: equipment vendors, substrate suppliers, and select OSATs may see improved order visibility as TXN’s internal network tightens lead times and expands share in constrained nodes. Competitively, ADI and NXPI are not “hurt” in absolute terms, but TXN’s internal capacity gives it a service-level advantage that can matter disproportionately in industrial and auto sockets where design wins are sticky but fulfillment reliability is decisive. If shortages re-emerge anywhere in the cycle, TXN is one of the few names that can monetize it without relying on foundry allocation.

The contrarian risk is valuation. The stock has already discounted a lot of the margin recovery, so the next leg higher likely requires evidence that utilization is still improving faster than depreciation normalization. If revenue growth stalls or channel inventories rebuild, the market will quickly reframe this as a capital intensity story rather than a margin expansion story, and the high forward multiple leaves limited room for disappointment over the next 1-2 quarters.

A subtler risk is that peers are also getting more efficient, which caps the relative upside from TXN’s manufacturing advantage. ADI’s and NXPI’s margin improvements suggest the sector is not suffering from a TXN-specific shortage of efficiency, so the main bullish argument is not category-wide re-rating but TXN’s ability to compound share gains while capex falls. That makes this more of a 6-12 month operating leverage trade than a long-duration compounder at current valuation.

Key Decisions for Investors

• Go long TXN on any 3-5% post-earnings pullback over the next 2-6 weeks; use a 6-9 month horizon and target outperformance from operating leverage as capex rolls over, but keep a tight stop if management signals utilization plateauing.
• Structure a pairs trade: long TXN / short NXPI or ADI for the next 1-2 quarters if you want relative margin expansion exposure; thesis is TXN’s internal manufacturing advantage should matter more as lead-time reliability becomes the scarce resource.
• Avoid adding to TXN into strength above ~40x forward earnings unless you have high conviction on continued upward EPS revisions; the risk/reward is less attractive once the market has fully priced the 2026 earnings rebound.
• If you want convexity, buy TXN 6-12 month calls financed by selling upside in a sector ETF; this expresses the view that earnings revisions and margin leverage will persist, while capping premium paid in a still-expensive name.
• Watch the next two quarterly prints for utilization and gross margin trajectory; if gross margin expands another 100bps+ with capex falling, that is the signal to extend the long, but if margins stall, reduce exposure quickly because the multiple can compress fast.